Works matching IS 2160763X AND DT 2025 AND VI 14 AND IP 5

Results: 8

Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P–Glycoprotein Inhibition.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 368, doi. 10.1002/cpdd.1526

By:

Jia, Hongxia;
Ballard, T. Eric;
Zhang, Liming;
Cohen, Lawrence;
Bergagnini‐Kolev, Mackenzie C.;
Templeton, Ian E.;
Jones, Hannah M.;
Yin, Wei

Publication type:

Article

Population Pharmacokinetics of Butylphthalide Injection in Elderly Chinese Patients With Ischemic Stroke.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 360, doi. 10.1002/cpdd.1525

By:

Lyu, Shu‐Xian;
Cui, Xue‐Yan;
Chen, Shi‐Xian;
Shi, Hai‐yan;
Huang, Xin

Publication type:

Article

Target‐Mediated Modeling of Alirocumab in Adolescents and Children ≥8 to <12 Years of Age Using Phase II and III Data.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 347, doi. 10.1002/cpdd.1523

By:

Kovalenko, Pavel;
Harnisch, Lutz;
Mendell, Jeanne;
Wang, Yuhuan;
Davis, John D.;
DiCioccio, Albert Thomas

Publication type:

Article

Comparative Pharmacokinetics and Bioequivalence of 2 Formulations of Bosentan Dispersible Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 404, doi. 10.1002/cpdd.1516

By:

Huang, Zhaoming;
Yu, Panpan;
Hu, Jiawei;
Zhang, Wanyong

Publication type:

Article

A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of Dordaviprone and the Effects of Food on the Bioavailability of Dordaviprone in Healthy Adult Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 382, doi. 10.1002/cpdd.1512

By:

Faison, Shamia L.;
Batonga, Joelle;
Arumugham, Thangam;
Bartkus, Angela;
Morrison, Marion;
Mullin, Mark J.;
Tippin, Tim;
Naderer, Odin

Publication type:

Article

Bioequivalence and Food Effect Assessment Between 2 Oral Tablet Formulations of Rivaroxaban 20 mg in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 391, doi. 10.1002/cpdd.1511

By:

Tang, Kaixian;
Chen, Yingrong;
Mei, Jue;
Bo, Hui;
Liu, Qing;
Wang, Wei;
Xu, Min;
Jin, Qiuyue;
Yang, Shuixin

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 343, doi. 10.1002/cpdd.1282
Publication type:: Article

Pharmacokinetics and Bioequivalence of 2 Products of Fluticasone Propionate Nasal Spray in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 398, doi. 10.1002/cpdd.1507

By:

Wang, Pengkai;
Li, Yuan;
Xu, Bing;
Zhang, Ping;
Cui, Chang;
Li, Xin

Publication type:

Article